Atlas FDA

Skinvive™ by Juvéderm®

FDA premarket approval P110033/S076 · decided 2023-07-06

Approval details

PMA number
P110033
Supplement
S076
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Skinvive™ by Juvéderm®
Generic name
Implant, dermal, for aesthetic use
Applicant
Allergan
Date received
2023-06-09
Decision date
2023-07-06
Days to decision
27 days
Decision code
OK30
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Irvine, CA
Statement
Duplicate mixer to be used during the manufacturing process for Skinvive by Juvéderm.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
NATRELLE INSPIRA Single Use Sizers for Gel Implants (K203229)Allergan2021-06-02
TrueTear Intranasal Tear Neurostimulator (K193589)Allergan2020-08-31
Natrelle 133 Plus MICROCELL Tissue Expander (K180826)Allergan2018-12-21
Natrelle 133S Tissue Expander (K182054)Allergan2018-08-29
TrueTear Intranasal Tear Neurostimulator (DEN170086)Allergan2018-05-17
SERI SURGICAL SCAFFOLD (K123128)Allergan2013-04-25